Drug actions on dopamine turnover in the median eminence.
D015107:4-Butyrolactone / Q000494:pharmacology; D000818:Animals; D001418:Baclofen / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism* / Q000502:physiology; D018492:Dopamine Antagonists; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D008473:Median Eminence / Q000187:drug effects / Q000378:metabolism*; D008781:Methyltyrosines / Q000494:pharmacology; D011388:Prolactin / Q000494:pharmacology; D051381:Rats
D018492:Dopamine Antagonists; D008781:Methyltyrosines; D011388:Prolactin; D001418:Baclofen; D006220:Haloperidol; D015107:4-Butyrolactone; D004298:Dopamine